KORU Medical Systems, Inc.
NCM: KRMDLive Quote
📈 ZcoreAI Score
Our AI model analyzes KORU Medical Systems, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get KRMD Z-Score →About KORU Medical Systems, Inc.
Healthcare
Medical Instruments & Supplies
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
📊 Fundamental Analysis
KORU Medical Systems, Inc. demonstrates a profit margin of -6.4%, which is below the sector average, suggesting competitive pressure.
The company recently reported 23.3% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -15.6%, which indicates that capital utilization is currently under pressure.
At a current price of $4.21, KRMD currently sits at the 47th percentile of its 52-week range (Range: $2.08 - $6.61).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$195.82M
Trailing P/E
--
Forward P/E
49.53
Beta (5Y)
0.54
52W High
$6.61
52W Low
$2.08
Avg Volume
197K
Day High
Day Low